<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi Med J</journal-id><journal-id journal-id-type="iso-abbrev">Saudi Med J</journal-id><journal-title-group><journal-title>Saudi Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">0379-5284</issn><publisher><publisher-name>Saudi Medical Journal</publisher-name><publisher-loc>Saudi Arabia</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27464860</article-id><article-id pub-id-type="pmc">5018700</article-id><article-id pub-id-type="publisher-id">SaudiMedJ-37-847</article-id><article-id pub-id-type="doi">10.15537/smj.2016.8.14822</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of different dosages of oxycodone and fentanyl on the hemodynamic changes during intubation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Park</surname><given-names>Ki-Bum</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ann</surname><given-names>Junggun</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Haemi</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff1"><italic>From the Department of Anesthesiology and Pain Medicine (Park), School of Medicine, Keimyung University Dongsan Hospital, and the Department of Anesthesiology and Pain Medicine (Ann &amp; Lee), College of Medicine, Yeungnam University, Daegu, Korea</italic></aff><author-notes><corresp id="cor1"><italic>Address correspondence and reprint request to: Dr. Haemi Lee, Department of Anesthesia and Pain Medicine, College of Medicine, Yeungnam University, Daegu, Korea. E-mail: <email xlink:href="hmlee@yu.ac.kr">hmlee@yu.ac.kr</email></italic></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2016</year></pub-date><volume>37</volume><issue>8</issue><fpage>847</fpage><lpage>852</lpage><history><date date-type="received"><day>29</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>02</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: © Saudi Medical Journal</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3138" xml_f="3149" txt_i="11" txt_f="22">Objectives:</offsets></title><p><offsets xml_i="3160" xml_f="3301" txt_i="23" txt_f="164">To investigate the effectiveness of oxycodone compared with fentanyl for attenuating the hemodynamic response during endotracheal intubation.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3332" xml_f="3340" txt_i="166" txt_f="174">Methods:</offsets></title><p><offsets xml_i="3351" xml_f="3918" txt_i="175" txt_f="742">This study was conducted from June 2014 to February 2015 on healthy adults undergoing general anesthesia at the Yeungnam University Hospital, Daegu, Republic of Korea. Ninety-five patients were randomly assigned to one of 3 groups to receive the following drugs; Group F: fentanyl 2 µg/kg; Group O/70: oxycodone 140 µg/kg; Group O/100: oxycodone 200 µg/kg. Five minutes after injection of the study drug, general anesthesia was induced with propofol 1.5 mg/kg and rocuronium 0.8 mg/kg. The mean blood pressure (MBP), heart rate (HR), peripheral oxygen saturation (SpO</offsets><sub><offsets xml_i="3923" xml_f="3924" txt_i="742" txt_f="743">2</offsets></sub><offsets xml_i="3930" xml_f="4189" txt_i="743" txt_f="1002">), and bispectral index (BIS) were compared before administration of the study drug (T1), just before endotracheal intubation (T2), one minute after endotracheal intubation (T3), and 7.5 minutes after endotracheal intubation (T4). Complications were assessed.</offsets></p></sec><sec id="st3"><title><offsets xml_i="4220" xml_f="4228" txt_i="1004" txt_f="1012">Results:</offsets></title><p><offsets xml_i="4239" xml_f="4311" txt_i="1013" txt_f="1085">The 2 oxycodone groups showed no significant differences in MBP, HR, SpO</offsets><sub><offsets xml_i="4316" xml_f="4317" txt_i="1085" txt_f="1086">2</offsets></sub><offsets xml_i="4323" xml_f="4445" txt_i="1086" txt_f="1208">, and BIS compared to Group F at the time points assessed. The incidence of complications was comparable among the groups.</offsets></p></sec><sec id="st4"><title><offsets xml_i="4476" xml_f="4488" txt_i="1210" txt_f="1222">Conclusions:</offsets></title><p><offsets xml_i="4499" xml_f="4770" txt_i="1223" txt_f="1494">Oxycodone could successfully be used to attenuate the sympathetic response during anesthetic induction. The hemodynamic profiles and incidence of complications were clinically similar among the groups, but Group O/70 tended to show a lower rate of complications of apnea.</offsets></p></sec></abstract></article-meta></front><body><p><offsets xml_i="4823" xml_f="5098" txt_i="1503" txt_f="1778">Laryngoscopy and endotracheal tube insertion are accompanied by elevations in blood pressure (BP) and heart rate (HR) as a result of sympathetic stimulation. The response increases and reaches its maximum level within one minute and ends within 5−10 minutes after intubation.</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="5131" xml_f="5132" txt_i="1778" txt_f="1779">1</offsets></xref><offsets xml_i="5139" xml_f="5458" txt_i="1779" txt_f="2098"> These changes in BP and HR are well tolerated by healthy individuals; however, they may be fatal in patients with cardiovascular diseases or those with increased intracranial pressure. Opioids, a2-agonists, b-blockers, vasodilators, lidocaine, or magnesium sulfate have been used to reduce these hemodynamic responses.</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="5491" xml_f="5492" txt_i="2098" txt_f="2099">2</offsets></xref><offsets xml_i="5499" xml_f="5500" txt_i="2099" txt_f="2100">-</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="5533" xml_f="5534" txt_i="2100" txt_f="2101">8</offsets></xref><offsets xml_i="5541" xml_f="5885" txt_i="2101" txt_f="2445"> The effectiveness of these drugs to blunt sympathetic stimulation has been found to be quite different throughout medical literature, because it was studied in different settings in relation to dose or route of drugs or type of surgery. Among the opioids, medications with rapid onset such as fentanyl have been commonly used for this purpose.</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="5918" xml_f="5919" txt_i="2445" txt_f="2446">1</offsets></xref><offsets xml_i="5926" xml_f="5927" txt_i="2446" txt_f="2447">,</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="5960" xml_f="5961" txt_i="2447" txt_f="2448">9</offsets></xref><offsets xml_i="5968" xml_f="6175" txt_i="2448" txt_f="2655"> In the relevant studies with fentanyl, the optimal dosage and time of administration to successfully attenuate the sympathetic response was found to be 2 µg/kg at 5 minutes prior to endotracheal intubation.</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="6209" xml_f="6211" txt_i="2655" txt_f="2657">10</offsets></xref><offsets xml_i="6218" xml_f="6410" txt_i="2657" txt_f="2849"> Recently, oxycodone has been used for the control of chronic pain, cancer pain, or post-operative pain in the form of intermittent intravenous (IV) injections or patient-controlled analgesia.</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="6444" xml_f="6446" txt_i="2849" txt_f="2851">11</offsets></xref><offsets xml_i="6453" xml_f="6454" txt_i="2851" txt_f="2852">-</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="6488" xml_f="6490" txt_i="2852" txt_f="2854">13</offsets></xref><offsets xml_i="6497" xml_f="6960" txt_i="2854" txt_f="3317"> However, its potency has not yet been accurately determined, and most studies show the conversion ratio of oxycodone versus morphine as 1:1. The potency ratio between fentanyl and oxycodone has not been investigated clearly and is simply assumed to be 1:100. However, some studies comparing postoperative pain scores concluded that the potency ratio of fentanyl to oxycodone might be approximately 1:75 or that oxycodone might be more potent than morphine (4:3).</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="6994" xml_f="6996" txt_i="3317" txt_f="3319">12</offsets></xref><offsets xml_i="7003" xml_f="7004" txt_i="3319" txt_f="3320">,</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="7038" xml_f="7040" txt_i="3320" txt_f="3322">13</offsets></xref><offsets xml_i="7047" xml_f="7474" txt_i="3322" txt_f="3749"> There have been no previous studies that have investigated the use of oxycodone to reduce the hemodynamic response during endotracheal intubation. So far, the effects of oxycodone and its optimal dosage during endotracheal intubation have not been studied. Therefore, we investigated the action and side effects during endotracheal intubation of IV oxycodone 140 µg/kg (1:70) or 200 µg/kg (1:100) compared to fentanyl 2 µg/kg.</offsets></p><sec sec-type="methods" id="sec1-2"><title><offsets xml_i="7521" xml_f="7528" txt_i="3750" txt_f="3757">Methods</offsets></title><p><offsets xml_i="7539" xml_f="8242" txt_i="3758" txt_f="4458">This prospective, randomized, double-blind designed study was carried out between June 2014 and February 2015 at the Yeungnam University Hospital, Daegu, Republic of Korea in accordance with the principles of the Helsinki Declaration and after obtaining approval of the study from the institutional ethics committee and written informed consent from participants. Ninety-five patients, 18-65 years old, the American Society of Anesthesiologists (ASA) physical status 1-2, undergoing general anesthesia, were included in this study. Exclusion criteria included heart disease, hypertension, diabetes, severe obesity (body mass index &gt;30), history of difficult intubation, or predicted difficult airway.</offsets></p><p><offsets xml_i="8249" xml_f="8374" txt_i="4459" txt_f="4584">The patients were randomized using a computer randomization program into one of 3 groups: Group F: fentanyl 2 µg/kg (Fentanyl</offsets><sup><offsets xml_i="8379" xml_f="8380" txt_i="4584" txt_f="4585">®</offsets></sup><offsets xml_i="8386" xml_f="8436" txt_i="4585" txt_f="4635">, Myungmun, Korea), Group O/70: oxycodone (Oxynorm</offsets><sup><offsets xml_i="8441" xml_f="8442" txt_i="4635" txt_f="4636">®</offsets></sup><offsets xml_i="8448" xml_f="9076" txt_i="4636" txt_f="5264">, Mundipharma, UK) 140 µg/kg (1:70), Group O/100: oxycodone 200 µg/kg (1:100). Two anesthesiologists conducted the study. One was responsible for preparing the study drug, and the other for performing the anesthesia and assessing the side effects. Both the assessor and patients were blind to the group allocations and were not informed of the block size until the end of the study. Oxycodone and fentanyl were prepared in 10 mL syringes, and normal saline was added to a final volume of 5 mL to create an identical appearance. Then, the drugs were consecutively injected to each patient according to the randomization schedule.</offsets></p><p><offsets xml_i="9083" xml_f="9800" txt_i="5265" txt_f="5982">Midazolam 0.03 mg/kg was IV injected into the patients for premedication in the preoperative holding area. In the operating room, routine monitoring devices were applied including electrocardiography (ECG), non-invasive BP, pulse oximetry, and bispectral index (BIS). After confirmation of baseline vital signs, the study drug was injected and the patients were carefully monitored for 5 minutes. During this period, patients were assessed for complications of opioid administration, particularly respiratory depression, hypotension, bradycardia, dizziness, chest stiffness, and pruritus. After that, propofol 1.5 mg/kg and rocuronium 0.8 mg/kg were injected to facilitate endotracheal intubation. Oxygen and air (FiO</offsets><sub><offsets xml_i="9805" xml_f="9806" txt_i="5982" txt_f="5983">2</offsets></sub><offsets xml_i="9812" xml_f="10250" txt_i="5983" txt_f="6418"> 0.5) were delivered during the induction period. After the achievement of deep neuromuscular block confirmed by train of Four (TOF) monitoring, endotracheal intubation was performed, and sevoflurane 1.5% was added. If systolic BP (SBP) increased &gt;150 mm Hg after intubation, sevoflurane was increased 0.5% in a timely manner and BP was rechecked every 2.5 minutes. Vital signs including SBP, diastolic BP (DBP), mean BP (MBP), HR, SpO</offsets><sub><offsets xml_i="10255" xml_f="10256" txt_i="6418" txt_f="6419">2</offsets></sub><offsets xml_i="10262" xml_f="10696" txt_i="6419" txt_f="6841">, and BIS were recorded before administration of the study drug (T1), just before intubation (T2), one minute after intubation (T3), and 7.5 minutes after intubation (T4). In case of hypotension (SBP &lt;90 mm Hg), or bradycardia (HR &lt;60 beats per minute [bpm]), ephedrine 4 mg, or atropine 250 µg, respectively, were injected. When hypertension (SBP &gt;180 mm Hg), or tachycardia (HR &gt;120 bpm) occurred, nicardipine (Perdipine</offsets><sup><offsets xml_i="10701" xml_f="10702" txt_i="6841" txt_f="6842">®</offsets></sup><offsets xml_i="10708" xml_f="10768" txt_i="6842" txt_f="6902">, Astellas Korea, Seoul, Korea) 500 µg or esmolol (Brevibloc</offsets><sup><offsets xml_i="10773" xml_f="10774" txt_i="6902" txt_f="6903">®</offsets></sup><offsets xml_i="10780" xml_f="10902" txt_i="6903" txt_f="7025">, Jeil Pharmaceutical Co., Ltd., Seoul, Korea) 20 mg, respectively, were administrated. Hypoventilation was defined as SpO</offsets><sub><offsets xml_i="10907" xml_f="10908" txt_i="7025" txt_f="7026">2</offsets></sub><offsets xml_i="10914" xml_f="11172" txt_i="7026" txt_f="7281"> &lt;90% during the 5 minutes after study drug administration, and when it occurred, the patient was encouraged to breathe deeply. If oxygen saturation did not recover, oxygen supply via face mask or manual assistance with ventilation was applied, as needed.</offsets></p><p><offsets xml_i="11179" xml_f="11851" txt_i="7282" txt_f="7954">This prospective investigation was performed as a preliminary study because there were no previous reports about the use of oxycodone as an adjuvant to tracheal intubation. An effect size of 0.38 and a sample size of 24 participants per group were found to provide a 10% difference in MBP at one minute after tracheal intubation with a power of 0.8 and a type one error of 0.05. In consideration of a dropout rate of about 10%, 95 patients were enrolled in this study. Data was computed and analyzed by using Statistical Package of Social Sciences Version 18.0 (SPSS Inc., Chicago, IL, USA). Repeated measures analysis of variance (ANOVA) were used to analyze MBP, HR, SpO</offsets><sub><offsets xml_i="11856" xml_f="11857" txt_i="7954" txt_f="7955">2</offsets></sub><offsets xml_i="11863" xml_f="12060" txt_i="7955" txt_f="8152">, and BIS, and the Bonferroni procedure was used for post hoc testing. Categorical data was analyzed with the chi-square test and continuous variables were analyzed using one-way ANOVA. A value of </offsets><italic><offsets xml_i="12068" xml_f="12069" txt_i="8152" txt_f="8153">p</offsets></italic><offsets xml_i="12078" xml_f="12128" txt_i="8153" txt_f="8200">&lt;0.05 was considered statistically significant.</offsets></p></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="12181" xml_f="12188" txt_i="8202" txt_f="8209">Results</offsets></title><p><offsets xml_i="12199" xml_f="12402" txt_i="8210" txt_f="8413">Of the 95 patients enrolled, 2 patients were excluded because of protocol violations. The analysis was performed on the remaining 93 patients, and there were no demographic differences among the groups (</offsets><bold><xref ref-type="table" rid="T1"><offsets xml_i="12440" xml_f="12447" txt_i="8413" txt_f="8420">Table 1</offsets></xref></bold><offsets xml_i="12461" xml_f="12541" txt_i="8420" txt_f="8500">). There were no differences in basal hemodynamic parameters among the 3 groups.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="12589" xml_f="12596" txt_i="8501" txt_f="8508">Table 1</offsets></label><caption><p><offsets xml_i="12616" xml_f="12746" txt_i="8508" txt_f="8638">Demographic data on 93 healthy adults undergoing general anesthesia at the Yeungnam University Hospital, Daegu, Republic of Korea.</offsets></p></caption><graphic xlink:href="SaudiMedJ-37-847-g001"></graphic></table-wrap><sec id="sec2-1"><title><offsets xml_i="12851" xml_f="12876" txt_i="8639" txt_f="8664">Mean blood pressure (MBP)</offsets></title><p><offsets xml_i="12887" xml_f="13397" txt_i="8665" txt_f="9175">Mean blood pressure decreased after the administration of study drugs and induction agents, then increased immediately to reach a level around baseline after intubation, and subsequently declined progressively in all study groups. The oxycodone groups showed a more suppressed trend regarding MBP than Group F throughout the study period, but there were no significant differences among the groups. There were significant differences in all 3 groups in the values between the following time points: T1 and T2 (</offsets><italic><offsets xml_i="13405" xml_f="13406" txt_i="9175" txt_f="9176">p</offsets></italic><offsets xml_i="13415" xml_f="13435" txt_i="9176" txt_f="9196">=0.000), T1 and T4 (</offsets><italic><offsets xml_i="13443" xml_f="13444" txt_i="9196" txt_f="9197">p</offsets></italic><offsets xml_i="13453" xml_f="13473" txt_i="9197" txt_f="9217">=0.000), T2 and T3 (</offsets><italic><offsets xml_i="13481" xml_f="13482" txt_i="9217" txt_f="9218">p</offsets></italic><offsets xml_i="13491" xml_f="13511" txt_i="9218" txt_f="9238">=0.000), T2 and T4 (</offsets><italic><offsets xml_i="13519" xml_f="13520" txt_i="9238" txt_f="9239">p</offsets></italic><offsets xml_i="13529" xml_f="13553" txt_i="9239" txt_f="9263">=0.000), and T3 and T4 (</offsets><italic><offsets xml_i="13561" xml_f="13562" txt_i="9263" txt_f="9264">p</offsets></italic><offsets xml_i="13571" xml_f="13624" txt_i="9264" txt_f="9317">=0.000), but no differences were found at T1 and T3 (</offsets><italic><offsets xml_i="13632" xml_f="13633" txt_i="9317" txt_f="9318">p</offsets></italic><offsets xml_i="13642" xml_f="13651" txt_i="9318" txt_f="9327">=1.000) (</offsets><bold><xref ref-type="fig" rid="F1"><offsets xml_i="13687" xml_f="13695" txt_i="9327" txt_f="9335">Figure 1</offsets></xref></bold><offsets xml_i="13709" xml_f="13711" txt_i="9335" txt_f="9337">).</offsets></p><fig id="F1" position="float"><label><offsets xml_i="13752" xml_f="13760" txt_i="9338" txt_f="9346">Figure 1</offsets></label><caption><p><offsets xml_i="13780" xml_f="14178" txt_i="9346" txt_f="9744">Changes in mean blood pressure (MBP) in each group during study period (mean ± standard deviation [SD]). Group F: fentanyl (2 µg/kg), Group O/70: oxycodone 140 µg/kg, Group O/100: oxycodone 200 µg/kg. T1 = baseline, T2 = just before intubation, T3 = one minute after intubation, T4 = 7.5 minutes after intubation. MBP showed no significant difference among the 3 groups at all periods of induction.</offsets></p></caption><graphic xlink:href="SaudiMedJ-37-847-g002"></graphic></fig></sec><sec id="sec2-2"><title><offsets xml_i="14282" xml_f="14297" txt_i="9746" txt_f="9761">Heart rate (HR)</offsets></title><p><offsets xml_i="14308" xml_f="14739" txt_i="9762" txt_f="10193">Compared to baseline, HR decreased just before intubation and peaked at T3 and then decreased progressively in all study groups. The trend of Group O/70 showed a less depressed pattern than that of Group F, while Group O/100 showed a more depressed pattern than that of Group F, even though there were no significant differences between each of the 2 groups. There were significant differences in the values assessed at T1 and T2 (</offsets><italic><offsets xml_i="14747" xml_f="14748" txt_i="10193" txt_f="10194">p</offsets></italic><offsets xml_i="14757" xml_f="14777" txt_i="10194" txt_f="10214">=0.000), T1 and T3 (</offsets><italic><offsets xml_i="14785" xml_f="14786" txt_i="10214" txt_f="10215">p</offsets></italic><offsets xml_i="14795" xml_f="14815" txt_i="10215" txt_f="10235">=0.000), T1 and T4 (</offsets><italic><offsets xml_i="14823" xml_f="14824" txt_i="10235" txt_f="10236">p</offsets></italic><offsets xml_i="14833" xml_f="14853" txt_i="10236" txt_f="10256">=0.004), T2 and T3 (</offsets><italic><offsets xml_i="14861" xml_f="14862" txt_i="10256" txt_f="10257">p</offsets></italic><offsets xml_i="14871" xml_f="14891" txt_i="10257" txt_f="10277">=0.000), T2 and T4 (</offsets><italic><offsets xml_i="14899" xml_f="14900" txt_i="10277" txt_f="10278">p</offsets></italic><offsets xml_i="14909" xml_f="14933" txt_i="10278" txt_f="10302">=0.000), and T3 and T4 (</offsets><italic><offsets xml_i="14941" xml_f="14942" txt_i="10302" txt_f="10303">p</offsets></italic><offsets xml_i="14951" xml_f="14976" txt_i="10303" txt_f="10328">=0.000) in all 3 groups (</offsets><bold><xref ref-type="fig" rid="F2"><offsets xml_i="15012" xml_f="15020" txt_i="10328" txt_f="10336">Figure 2</offsets></xref></bold><offsets xml_i="15034" xml_f="15036" txt_i="10336" txt_f="10338">).</offsets></p><fig id="F2" position="float"><label><offsets xml_i="15077" xml_f="15085" txt_i="10339" txt_f="10347">Figure 2</offsets></label><caption><p><offsets xml_i="15105" xml_f="15453" txt_i="10347" txt_f="10695">Changes in heart rate (HR) in each group during study period. Group F: fentanyl (2 µg/kg), Group O/70: oxycodone 140 µg/kg, Group O/100: oxycodone 200 µg/kg. T1 = baseline, T2 = just before intubation, T3 = one minute after intubation, T4 = 7.5 minutes after intubation. A significant difference was noted between Group O/70 and Group O/100 at T3 (</offsets><italic><offsets xml_i="15461" xml_f="15462" txt_i="10695" txt_f="10696">p</offsets></italic><offsets xml_i="15471" xml_f="15478" txt_i="10696" txt_f="10703">=0.04).</offsets></p></caption><graphic xlink:href="SaudiMedJ-37-847-g003"></graphic></fig></sec><sec id="sec2-3"><title><offsets xml_i="15582" xml_f="15615" txt_i="10705" txt_f="10738">Peripheral oxygen saturation (SpO</offsets><sub><offsets xml_i="15620" xml_f="15621" txt_i="10738" txt_f="10739">2</offsets></sub><offsets xml_i="15627" xml_f="15628" txt_i="10739" txt_f="10740">)</offsets></title><p><offsets xml_i="15639" xml_f="15865" txt_i="10741" txt_f="10967">Peripheral oxygen saturation in Group O/70 increased immediately during anesthetic induction and then leveled off, while the other groups showed gradual increases. There were significant differences in time between T1 and T2 (</offsets><italic><offsets xml_i="15873" xml_f="15874" txt_i="10967" txt_f="10968">p</offsets></italic><offsets xml_i="15883" xml_f="15903" txt_i="10968" txt_f="10988">=0.000), T1 and T3 (</offsets><italic><offsets xml_i="15911" xml_f="15912" txt_i="10988" txt_f="10989">p</offsets></italic><offsets xml_i="15921" xml_f="15945" txt_i="10989" txt_f="11013">=0.000), and T1 and T4 (</offsets><italic><offsets xml_i="15953" xml_f="15954" txt_i="11013" txt_f="11014">p</offsets></italic><offsets xml_i="15963" xml_f="16017" txt_i="11014" txt_f="11068">=0.000), but no significant differences at T2 and T3 (</offsets><italic><offsets xml_i="16025" xml_f="16026" txt_i="11068" txt_f="11069">p</offsets></italic><offsets xml_i="16035" xml_f="16055" txt_i="11069" txt_f="11089">=1.000), T2 and T4 (</offsets><italic><offsets xml_i="16063" xml_f="16064" txt_i="11089" txt_f="11090">p</offsets></italic><offsets xml_i="16073" xml_f="16097" txt_i="11090" txt_f="11114">=0.447), and T3 and T4 (</offsets><italic><offsets xml_i="16105" xml_f="16106" txt_i="11114" txt_f="11115">p</offsets></italic><offsets xml_i="16115" xml_f="16196" txt_i="11115" txt_f="11196">=1.000) in all 3 groups. No significant differences were found among the groups (</offsets><bold><xref ref-type="fig" rid="F3"><offsets xml_i="16232" xml_f="16240" txt_i="11196" txt_f="11204">Figure 3</offsets></xref></bold><offsets xml_i="16254" xml_f="16256" txt_i="11204" txt_f="11206">).</offsets></p><fig id="F3" position="float"><label><offsets xml_i="16297" xml_f="16305" txt_i="11207" txt_f="11215">Figure 3</offsets></label><caption><p><offsets xml_i="16325" xml_f="16369" txt_i="11215" txt_f="11259">Changes in peripheral oxygen saturation (SpO</offsets><sub><offsets xml_i="16374" xml_f="16375" txt_i="11259" txt_f="11260">2</offsets></sub><offsets xml_i="16381" xml_f="16630" txt_i="11260" txt_f="11509">) in each group during study period. Group F: fentanyl (2 µg/kg), Group O/70: oxycodone 140 µg/kg, Group O/100: oxycodone 200 µg/kg. T1 = baseline, T2 = just before intubation, T3 = one minute after intubation, T4 = 7.5 minutes after intubation. SpO</offsets><sub><offsets xml_i="16635" xml_f="16636" txt_i="11509" txt_f="11510">2</offsets></sub><offsets xml_i="16642" xml_f="16693" txt_i="11510" txt_f="11561"> showed no significant difference among the groups.</offsets></p></caption><graphic xlink:href="SaudiMedJ-37-847-g004"></graphic></fig></sec><sec id="sec2-4"><title><offsets xml_i="16797" xml_f="16813" txt_i="11563" txt_f="11579">Bispectral index</offsets></title><p><offsets xml_i="16824" xml_f="17041" txt_i="11580" txt_f="11797">Anesthetic induction decreased BIS to approxiamtely the 40s in all groups, and then the values leveled off. Bispectral index was comparable in all groups. There were significant differences in time between T1 and T2 (</offsets><italic><offsets xml_i="17049" xml_f="17050" txt_i="11797" txt_f="11798">p</offsets></italic><offsets xml_i="17059" xml_f="17079" txt_i="11798" txt_f="11818">=0.000), T1 and T3 (</offsets><italic><offsets xml_i="17087" xml_f="17088" txt_i="11818" txt_f="11819">p</offsets></italic><offsets xml_i="17097" xml_f="17117" txt_i="11819" txt_f="11839">=0.000), T1 and T4 (</offsets><italic><offsets xml_i="17125" xml_f="17126" txt_i="11839" txt_f="11840">p</offsets></italic><offsets xml_i="17135" xml_f="17155" txt_i="11840" txt_f="11860">=0.000), T2 and T3 (</offsets><italic><offsets xml_i="17163" xml_f="17164" txt_i="11860" txt_f="11861">p</offsets></italic><offsets xml_i="17173" xml_f="17197" txt_i="11861" txt_f="11885">=0.000), and T2 and T4 (</offsets><italic><offsets xml_i="17205" xml_f="17206" txt_i="11885" txt_f="11886">p</offsets></italic><offsets xml_i="17215" xml_f="17269" txt_i="11886" txt_f="11940">=0.000), but no significant differences at T3 and T4 (</offsets><italic><offsets xml_i="17277" xml_f="17278" txt_i="11940" txt_f="11941">p</offsets></italic><offsets xml_i="17287" xml_f="17296" txt_i="11941" txt_f="11950">=1.000) (</offsets><bold><xref ref-type="fig" rid="F4"><offsets xml_i="17332" xml_f="17340" txt_i="11950" txt_f="11958">Figure 4</offsets></xref></bold><offsets xml_i="17354" xml_f="17356" txt_i="11958" txt_f="11960">).</offsets></p><fig id="F4" position="float"><label><offsets xml_i="17397" xml_f="17405" txt_i="11961" txt_f="11969">Figure 4</offsets></label><caption><p><offsets xml_i="17425" xml_f="17736" txt_i="11969" txt_f="12280">Changes in bispectral index (BIS) in each group during study period. Group F: fentanyl (2 µg/kg), Group O/70: oxycodone 140 µg/kg, Group O/100: oxycodone 200 µg/kg. T1 = baseline, T2 = just before intubation, T3 = one minute after intubation, T4 = 7.5 minutes after intubation. BIS was comparable in all groups.</offsets></p></caption><graphic xlink:href="SaudiMedJ-37-847-g005"></graphic></fig></sec><sec id="sec2-5"><title><offsets xml_i="17840" xml_f="17852" txt_i="12282" txt_f="12294">Side effects</offsets></title><p><offsets xml_i="17863" xml_f="17993" txt_i="12295" txt_f="12425">The incidence of side effects such as hypotension, hypertension, tachycardia, and bradycardia during the study period is shown in </offsets><bold><xref ref-type="table" rid="T2"><offsets xml_i="18031" xml_f="18038" txt_i="12425" txt_f="12432">Table 2</offsets></xref></bold><offsets xml_i="18052" xml_f="18468" txt_i="12432" txt_f="12848">. The incidence of all side effects was comparable, but one patient in Group O/100 showed a decrease in HR to 22 bpm at T2, and was successfully treated with 0.5 mg of IV atropine. The incidence of hypoventilation was lower in Group O/70 (n=7) compared to Group F (n=12) and Group O/100 (n=13), but there was no significant statistical difference. The total incidence of side effects was comparable among the groups.</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="18516" xml_f="18523" txt_i="12849" txt_f="12856">Table 2</offsets></label><caption><p><offsets xml_i="18543" xml_f="18682" txt_i="12856" txt_f="12995">Incidence of side effects on 93 healthy adults undergoing general anesthesia at the Yeungnam University Hospital, Daegu, Republic of Korea.</offsets></p></caption><graphic xlink:href="SaudiMedJ-37-847-g006"></graphic></table-wrap></sec></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="18821" xml_f="18831" txt_i="12998" txt_f="13008">Discussion</offsets></title><p><offsets xml_i="18842" xml_f="19804" txt_i="13009" txt_f="13971">There had been no previous studies that compared the effectiveness of IV oxycodone and fentanyl to reduce the hemodynamic response during endotracheal intubation. In the current study, the hemodynamic responses of the 3 drug regimens were similar, and the incidence of complications was also comparable. Endotracheal intubation and laryngoscopy are almost always accompanied by increases in BP and HR, so various medications have been used to blunt such stimulations. However, no agent has yet been revealed to be superior to the others, and they are used in combination according to patients’ physical status. Opioids are widely used for this purpose, but they are often accompanied by hypotension before intubation or during surgical draping. Hypotension after the administration of induction agents pushes anesthesiologists to perform hasty intubation. If sufficient muscle relaxation is not achieved, intubation could cause vocal cord contractions or injury.</offsets><xref rid="ref14" ref-type="bibr"><offsets xml_i="19838" xml_f="19840" txt_i="13971" txt_f="13973">14</offsets></xref><offsets xml_i="19847" xml_f="20494" txt_i="13973" txt_f="14620"> Also, hypotension often appears during the time between endotracheal intubation and the initiation of surgery; therefore, induction agents should have adequate hemodynamic profiles during the entire period of anesthetic induction. In the current study, MBPs were all above 60 mm Hg, even during the anesthetic induction, and the overall difference showed no statistical significance among the groups. There were no significant differences in complications among the groups; therefore, we conclude that oxycodone has clinically similar hemodynamic effects to those of fentanyl during induction of general anesthesia, both in 1:70 and 1:100 ratios.</offsets></p><p><offsets xml_i="20501" xml_f="21145" txt_i="14621" txt_f="15265">Although the difference was not significant in this study, the overall trend showed lower MBP in the oxycodone groups. The reason is unclear but we hypothesized 3 possible explanations. First, the synergistic effect of propofol and oxycodone might be higher than that of propofol and fentanyl. Second, histamine released by oxycodone might induce decreased MBP. The potency of opioids has been compared in many studies with pain scores, not by hemodynamic profiles. For instance, as oxycodone does not release significant amounts of histamine, as morphine does, oxycodone has been found to decrease BP less than morphine at equianalgesic doses.</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="21179" xml_f="21181" txt_i="15265" txt_f="15267">11</offsets></xref><offsets xml_i="21188" xml_f="21189" txt_i="15267" txt_f="15268">,</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="21223" xml_f="21225" txt_i="15268" txt_f="15270">15</offsets></xref><offsets xml_i="21232" xml_f="21322" txt_i="15270" txt_f="15360"> However, fentanyl belongs to the piperidine group and does not produce histamine release.</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="21356" xml_f="21358" txt_i="15360" txt_f="15362">16</offsets></xref><offsets xml_i="21365" xml_f="21725" txt_i="15362" txt_f="15722"> This may contribute to the MBP difference even at equianalgesic doses of oxycodone and fentanyl. Third, oxycodone exhibits effects by binding the µ-opioid receptor, like other opioids. However, in animal studies, oxycodone has been revealed to have an additional antinociceptive profile through the k-receptor, which is located prudently on peripheral nerves.</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="21759" xml_f="21761" txt_i="15722" txt_f="15724">17</offsets></xref><offsets xml_i="21768" xml_f="21935" txt_i="15724" txt_f="15891"> K-receptor agonists, U-50 and 488H, have been reported to decrease left systolic peak pressure and HR in isolated rat hearts, which was not antagonized with naloxone.</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="21969" xml_f="21971" txt_i="15891" txt_f="15893">18</offsets></xref><offsets xml_i="21978" xml_f="22117" txt_i="15893" txt_f="16032"> And another k-receptor agonist, dynorphin, has been reported to decrease mean arterial pressure and dilate the superior mesenteric artery.</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="22151" xml_f="22153" txt_i="16032" txt_f="16034">19</offsets></xref><offsets xml_i="22160" xml_f="22349" txt_i="16034" txt_f="16223"> That might affect MBP in both oxycodone groups even though there is no significance. Oxycodone is a semi-synthetic opioid analgesic derived from the naturally occurring alkaloid, thebaine.</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="22383" xml_f="22385" txt_i="16223" txt_f="16225">17</offsets></xref><offsets xml_i="22392" xml_f="22558" txt_i="16225" txt_f="16391"> Its onset is similar to that of fentanyl (2-3 min after IV injection) and its duration of action is slightly longer (t1/2: 4 hours 52 min versus 3 hours 39 minutes).</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="22592" xml_f="22594" txt_i="16391" txt_f="16393">12</offsets></xref><offsets xml_i="22601" xml_f="22737" txt_i="16393" txt_f="16529"> As the k-receptor is associated with visceral pain, the effect of oxycodone is better than that of morphine in intra-abdominal surgery.</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="22771" xml_f="22773" txt_i="16529" txt_f="16531">13</offsets></xref><offsets xml_i="22780" xml_f="22969" txt_i="16531" txt_f="16720"> Also, in a comparison of oxycodone and fentanyl in postoperative pain control after laparoscopic cholecystectomy, 15 mg of oxycodone showed better analgesic effect than 200 µg of fentanyl.</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="23003" xml_f="23005" txt_i="16720" txt_f="16722">12</offsets></xref><offsets xml_i="23012" xml_f="23140" txt_i="16722" txt_f="16850"> These findings suggest that the potency ratio between oxycodone and fentanyl is not 1:100 in surgeries involving visceral pain.</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="23174" xml_f="23176" txt_i="16850" txt_f="16852">12</offsets></xref></p><sec id="sec2-6"><title><offsets xml_i="23211" xml_f="23228" txt_i="16853" txt_f="16870">Study limitations</offsets></title><p><offsets xml_i="23239" xml_f="23433" txt_i="16871" txt_f="17065">Subjectively, complications were assessed by incidence rather than by severity. For instance, in one patient in Group O/100, manual ventilation was required to recover saturation from 66-90% SpO</offsets><sub><offsets xml_i="23438" xml_f="23439" txt_i="17065" txt_f="17066">2</offsets></sub><offsets xml_i="23445" xml_f="23519" txt_i="17066" txt_f="17140">. The patient needed several stimulations or interventions to maintain SpO</offsets><sub><offsets xml_i="23524" xml_f="23525" txt_i="17140" txt_f="17141">2</offsets></sub><offsets xml_i="23531" xml_f="24365" txt_i="17141" txt_f="17975"> over 90%, but this result was interpreted as the same as desaturated patients who recovered oxygen saturation over 90% by a single stimulation only. In other words, only incidence but not magnitude of desaturation was assessed in this study. Also, dizziness, chest discomfort, and pruritus were assessed, but could not be considered in the results because the responses were not definite. Patients who were moderately sedated may have been confused or failed to answer the questions regarding these side effects. A high percentage of these patients belonged to Group O/100, even though BIS was comparable among the groups. Therefore, assessing unpurposed behaviors may have resulted in significant differences. Further studies are needed to establish the respiratory complications of oxycodone during the anesthetic induction period.</offsets></p><p><offsets xml_i="24372" xml_f="24717" txt_i="17976" txt_f="18321">In conclusion, oxycodone could be successfully used to attenuate the sympathetic response during endotracheal intubation as effectively as fentanyl. Although the exact conversion ratio between fentanyl and oxycodone could not be determined in this study, both 140 µg/kg and 200 µg/kg of oxycodone provided stable MBP during anesthetic induction.</offsets></p></sec></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p>
<boxed-text position="float"><p><bold>Disclosure.</bold> Authors have no conflict of interests, and the work was not supported or funded by any drug company.</p></boxed-text>
</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogus</surname><given-names>N</given-names></name><name><surname>Akan</surname><given-names>B</given-names></name><name><surname>Serger</surname><given-names>N</given-names></name><name><surname>Baydar</surname><given-names>M</given-names></name></person-group><article-title>The comparison of the effects of dexmedetomidine, fentanyl and esmolol on prevention of hemodynamic response to intubation</article-title><source>Rev Bras Anestesiol</source><year>2014</year><volume>64</volume><fpage>314</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">25168435</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sameenakousar</surname><given-names>Mahesh</given-names></name><name><surname>Srinivasan</surname><given-names>KV</given-names></name></person-group><article-title>Comparison of fentanyl and clonidine for attenuation of the haemodynamic response to laryngocopy and endotracheal intubation</article-title><source>J Clin Diagn Res</source><year>2013</year><volume>7</volume><fpage>106</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">23450003</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parida</surname><given-names>S</given-names></name><name><surname>Ashraf</surname><given-names>NC</given-names></name><name><surname>Mathew</surname><given-names>JS</given-names></name><name><surname>Mishra</surname><given-names>SK</given-names></name><name><surname>Badhe</surname><given-names>AS</given-names></name></person-group><article-title>Attenuation of the haemodynamic responses to tracheal intubation with gabapentin, fentanyl and a combination of both: A randomised controlled trial</article-title><source>Indian J Anaesth</source><year>2015</year><volume>59</volume><fpage>306</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">26019356</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>HT</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Lim</surname><given-names>SH</given-names></name><etal></etal></person-group><article-title>Comparison of dexmedetomidine and remifentanil for attenuation of hemodynamic responses to laryngoscopy and tracheal intubation</article-title><source>Korean J Anesthesiol</source><year>2012</year><volume>63</volume><fpage>124</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">22949979</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cakirgoz</surname><given-names>MY</given-names></name><name><surname>Tasdogen</surname><given-names>A</given-names></name><name><surname>Olguner</surname><given-names>C</given-names></name><name><surname>Korkmaz</surname><given-names>H</given-names></name><name><surname>Ogun</surname><given-names>E</given-names></name><name><surname>Kucukebe</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>The effect of different doses of esmolol on hemodynamic, bispectral index and movement response during orotracheal intubation: prospective, randomized, double-blind study</article-title><source>Rev Bras Anestesiol</source><year>2014</year><volume>64</volume><fpage>425</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">25437700</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>NB</given-names></name><name><surname>Bharti</surname><given-names>N</given-names></name><name><surname>Prasad</surname><given-names>S</given-names></name></person-group><article-title>Minimal effective dose of magnesium sulfate for attenuation of intubation response in hypertensive patients</article-title><source>J Clin Anesth</source><year>2013</year><volume>25</volume><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">23333201</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>JH</given-names></name><name><surname>Apfel</surname><given-names>CC</given-names></name><name><surname>Whelan</surname><given-names>R</given-names></name><name><surname>Jeon</surname><given-names>YT</given-names></name><name><surname>Hwang</surname><given-names>JW</given-names></name><name><surname>Do</surname><given-names>SH</given-names></name><etal></etal></person-group><article-title>Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 µg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized, double-blind study</article-title><source>Clin Ther</source><year>2012</year><volume>34</volume><fpage>593</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">22364823</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>DY</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>BX</given-names></name><name><surname>Xu</surname><given-names>FY</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal></etal></person-group><article-title>Efficacy of intravenous lidocaine versus placebo on attenuating cardiovascular response to laryngoscopy and tracheal intubation: a systematic review of randomized controlled trials</article-title><source>Minerva Anestesiol</source><year>2013</year><volume>79</volume><fpage>1423</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">23839320</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Channaiah</surname><given-names>VB</given-names></name><name><surname>Kurek</surname><given-names>NS</given-names></name><name><surname>Moses</surname><given-names>R</given-names></name><name><surname>Chandra</surname><given-names>SB</given-names></name></person-group><article-title>Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation with Pre Induction IV Fentanyl Versus Combination of IV Fentanyl and Sub Lingual Nitroglycerin Spray</article-title><source>Med Arch</source><year>2014</year><volume>68</volume><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">25568568</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>DC</given-names></name><name><surname>Han</surname><given-names>YJ</given-names></name><name><surname>Song</surname><given-names>HS</given-names></name></person-group><article-title>Small-dose fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation</article-title><source>Anesth Analg</source><year>1998</year><volume>86</volume><fpage>658</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">9495433</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalso</surname><given-names>E</given-names></name><name><surname>Poyhia</surname><given-names>R</given-names></name><name><surname>Onnela</surname><given-names>P</given-names></name><name><surname>Linko</surname><given-names>K</given-names></name><name><surname>Tigerstedt</surname><given-names>I</given-names></name><name><surname>Tammisto</surname><given-names>T</given-names></name></person-group><article-title>Intravenous morphine and oxycodone for pain after abdominal surgery</article-title><source>Acta Anaesthesiol Scand</source><year>1991</year><volume>35</volume><fpage>642</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">1785245</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>S</given-names></name><name><surname>Ahlburg</surname><given-names>P</given-names></name><name><surname>Spangsberg</surname><given-names>N</given-names></name><name><surname>Brock</surname><given-names>B</given-names></name><name><surname>Tonnesen</surname><given-names>E</given-names></name><name><surname>Nikolajsen</surname><given-names>L</given-names></name></person-group><article-title>Oxycodone vs. fentanyl in the treatment of early post-operative pain after laparoscopic cholecystectomy: a randomised double-blind study</article-title><source>Acta Anaesthesiol Scand</source><year>2008</year><volume>52</volume><fpage>845</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">18477082</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>H</given-names></name><name><surname>Sandvik</surname><given-names>L</given-names></name><name><surname>Qvigstad</surname><given-names>E</given-names></name><name><surname>Bjerkelund</surname><given-names>CE</given-names></name><name><surname>Raeder</surname><given-names>J</given-names></name></person-group><article-title>A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy</article-title><source>Anesth Analg</source><year>2009</year><volume>109</volume><fpage>1279</fpage><lpage>1283</lpage><pub-id pub-id-type="pmid">19762758</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mencke</surname><given-names>T</given-names></name><name><surname>Echternach</surname><given-names>M</given-names></name><name><surname>Kleinschmidt</surname><given-names>S</given-names></name><name><surname>Lux</surname><given-names>P</given-names></name><name><surname>Barth</surname><given-names>V</given-names></name><name><surname>Plinkert</surname><given-names>PK</given-names></name><etal></etal></person-group><article-title>Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial</article-title><source>Anesthesiology</source><year>2003</year><volume>98</volume><fpage>1049</fpage><lpage>1056</lpage><pub-id pub-id-type="pmid">12717124</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poyhia</surname><given-names>R</given-names></name><name><surname>Kalso</surname><given-names>E</given-names></name><name><surname>Seppala</surname><given-names>T</given-names></name></person-group><article-title>Pharmacodynamic interactions of oxycodone and amitriptyline in healthy volunteers</article-title><source>Current Therapeutic Research</source><year>1992</year><volume>51</volume><fpage>739</fpage><lpage>749</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prieto-Lastra</surname><given-names>L</given-names></name><name><surname>Iglesias-Cadarso</surname><given-names>A</given-names></name><name><surname>Reano-Martos</surname><given-names>MM</given-names></name><name><surname>Perez-Pimiento</surname><given-names>A</given-names></name><name><surname>Rodriguez-Cabreros</surname><given-names>MI</given-names></name><name><surname>Garcia-Cubero</surname><given-names>A</given-names></name></person-group><article-title>Pharmacological stimuli in asthma/urticaria</article-title><source>Allergol Immunopathol (Madr)</source><year>2006</year><volume>34</volume><fpage>224</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">17064652</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>FB</given-names></name><name><surname>Smith</surname><given-names>MT</given-names></name></person-group><article-title>The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated</article-title><source>Pain</source><year>1997</year><volume>73</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">9415500</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugsley</surname><given-names>MK</given-names></name><name><surname>Penz</surname><given-names>WP</given-names></name><name><surname>Walker</surname><given-names>MJ</given-names></name><name><surname>Wong</surname><given-names>TM</given-names></name></person-group><article-title>Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade</article-title><source>Br J Pharmacol</source><year>1992</year><volume>105</volume><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">1320979</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>SP</given-names></name><name><surname>Conley</surname><given-names>A</given-names></name><name><surname>Dunbar</surname><given-names>JC</given-names></name></person-group><article-title>Cardiovascular responses to central administration of mu and kappa opioid receptor agonist and antagonist in normal rats</article-title><source>Peptides</source><year>2003</year><volume>24</volume><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">12895662</pub-id></element-citation></ref></ref-list></back></article>